Seroprevalence of TORCH Infections in Pregnant Women Attending Antenatal Clinic in a Tertiary Care Hospital.

Sen MR, Shukla BN, Tuhina B. Prevalence of serum antibodies to TORCH infection in and around Varanasi, Northern India. J Clin Diag Res 2012;6(9):1483-5. 

Turbadkar D, Mathur M, Rele M. Seroprevalence of TORCH infection in Bad obstetric history. Indian J Med Microbiol 2003;21(2):108-10.       

Sarkar MD, Anuradha B, Sharma N, et al. Seropositivity of Toxoplasmosis in antenatal women with bad obstetric history in a tertiary care hospital of Andhra Pradesh, India. J Health Popul Nutr 2012;30(1):87-92.              

Kumari N, Morris N, Dutta R. Is screening of TORCH worthwhile in women with bad obstetric history: an observation from eastern Nepal. J Health Popul Nutr 2011;29(1):77-80.               

Wu D, Wu Y, Wang L, et al. Evaluation of a novel array- based toxoplasma, rubella, cyto megalovirus and herpes simplex virus IgG enzyme linked immunosorbent assay and its comparison with virion/serion Enzyme linked immunosorbent assays. Ann Lab Med 2014;34(1):38-42.                       

Nyholm JL, Schleiss MR. Prevention of maternal cytomegalovirus infection: current status and future prospects. Inter J Womens Health 2010;2:23-35.    

Ramana BV, Reddy K, Murty DS, et al. Seroprevalence of Rubella in women with bad obstetric history. J Fam Med Primary Care 2013;2(1):44-6.  

Alsibiani SA. Rubella immunity among pregnant women in Jeddah, Western region of Saudi Arabia. Article ID 659838, Obstet Gynecol Int 2014;2014: p. 6.       

Obeid OE. Prevalence of herpes simplex virus types 1 and 2 and associated sociodemographic variables in pregnant women attending King Fahd hospital of the University. J Family Community Med 2007;14(1):3-7.             

Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012;25(2):264-96.          

Gras L, Gilbert RE, Wallon M, et al. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: Implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect 2004;132(3):541-8.              

Razzak AH, Wais SA, Saeid AY. Toxoplasmosis: the innocent suspect of pregnancy wastage in Duhok, Iraq. Eas Med Health J 2005;11(4):625-32.        

Hani OG, Abdulwahab MT, Maho med FM. TORCH agents in pregnant Saudi women. Med Principles Pract 2002;11(4):180-2.            

Zemene E, Yewhalaw D, Abera S, et al. Seroprevalence of Toxoplasma gondii and associated risk factors among pregnant women in Jimma town, South western Ethiopia. BMC Infect Dis 2012;12:337.            

Sroka S, Bartelheimer N, Winter A, et al. Prevalence and risk factors of Toxoplasmosis among pregnant women in Fortaleza Northern Brazil. Am J Trop Med Hyg 2010;83(3):528-33.                                 

Song KJ, Shin JC, Shin HJ, et al. Seroprevalence of toxoplasmosis in Korean pregnant women. Korean J Parasitol 2005;43(2):69-71.          

Jenum PA, Kapperud G, Stray-Pedersen B, et al. Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect 1998;120(1):87-92.               

Mwambe B, Mirambo MM, Mshana SE, et al. Sero-positivity rate of rubella and associated factors among pregnant women attending antenatal care in Mwanza, Tanzania. BMC Pregnancy Childbirth 2014;14:95.               

Mohammed EAK, Salman YJ. Study of TORCH infections in women with Bad Obstetric History (BOH) in Kirkuk city. Int J Curr Microbiol App Sci 2014;3(10):700-9.           

Gandhoke I, Aggarwal R, Lal S, et al. Congenital CMV infection in sympto matic infants in Delhi and surrounding areas. Indian J Pediatr 2006;73(12):1095-7.       

Duran N, Yarkin F, Evruke C, et al. Asymptomatic herpes simplex virus type 2 (HSV-2) infection among pregnant women in Turkey. Indian J Med Res 2004;120(2):106-10.             

Biswas D, Borkakoty B, Mahanta J, et al. Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast India. BMC Infectious Diseases 2011;11:325.              

Delaney S, Gardella RC, Saracino M, et al. Seroprevalence of herpes simplex virus types 1 and 2 among pregnant women, 1989-2010. JAMA 2014;312(7):746-8.